Organic Process Research & Development最新文献

筛选
英文 中文
Can a Simple Surrogate Model System Be Used to Develop a Continuous Flow Packed Bed Hydrogenation for a Complex Molecule? 一个简单的替代模型系统能否用于开发复杂分子的连续流动填充床加氢?
IF 3.4 3区 化学
Organic Process Research & Development Pub Date : 2025-01-15 DOI: 10.1021/acs.oprd.4c00411
Stefano Martinuzzi, Martin Mex, Jelena Milic, Christopher A. Hone, C. Oliver Kappe
{"title":"Can a Simple Surrogate Model System Be Used to Develop a Continuous Flow Packed Bed Hydrogenation for a Complex Molecule?","authors":"Stefano Martinuzzi, Martin Mex, Jelena Milic, Christopher A. Hone, C. Oliver Kappe","doi":"10.1021/acs.oprd.4c00411","DOIUrl":"https://doi.org/10.1021/acs.oprd.4c00411","url":null,"abstract":"Catalytic hydrogenations are key processes in the fine chemical and pharmaceutical industries, but the development of such processes is challenging due to aspects such as catalyst deactivation, metal leaching, mass transfer limitations, solubility issues, and the formation of side products. Processes are particularly difficult to develop when a substrate is a large molecule containing multiple functional groups. These difficulties are significant obstacles for the identification of robust operating conditions; thus, workflows are necessary to speed up development timelines. The use of a more cost-effective and commercially available surrogate in development is an alternative strategy to find the optimized conditions, which can then be subsequently validated on the real molecule only at a later stage in development. The approach we apply herein is designed to use less of the real compound while minimizing the perceived risk of failure when transferring the conditions to the complex molecule. In this article, we apply our workflow for the catalytic hydrogenolysis of a large glycopeptide molecule, Cbz-protected glycopeptide (Cbz-GP), in a packed bed reactor. As part of the workflow, we use a robustness screening approach, introduced by Collins and Glorius, to show that a surrogate molecule, Cbz-protected lysine (Cbz-Lys), in the presence of additives can mimic secondary functional groups present in Cbz-GP or represent residual impurities generated upstream in the synthesis of Cbz-GP. The data generated for Cbz-Lys enabled the identification of the operating conditions for the successful deprotection of Cbz-GP after minor modification. Gratifyingly, only a few additional experiments were necessary using the Cbz-protected GP molecule to modify the conditions to achieve >95% conversion under mild conditions and within <10 s of contact time for stable performance over >6 h operation time.","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"31 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142981920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scaling Up Gas–Liquid Photo-Oxidations in Flow Using Rotor-Stator Spinning Disc Reactors and a High-Intensity Light Source 利用转子-定子旋转盘反应器和高强度光源放大流动中的气液光氧化
IF 3.4 3区 化学
Organic Process Research & Development Pub Date : 2025-01-14 DOI: 10.1021/acs.oprd.4c00458
Arnab Chaudhuri, Wouter F.C. de Groot, Jasper H.A. Schuurmans, Stefan D.A. Zondag, Alessia Bianchi, Koen P.L. Kuijpers, Rémy Broersma, Amin Delparish, Matthieu Dorbec, John van der Schaaf, Timothy Noël
{"title":"Scaling Up Gas–Liquid Photo-Oxidations in Flow Using Rotor-Stator Spinning Disc Reactors and a High-Intensity Light Source","authors":"Arnab Chaudhuri, Wouter F.C. de Groot, Jasper H.A. Schuurmans, Stefan D.A. Zondag, Alessia Bianchi, Koen P.L. Kuijpers, Rémy Broersma, Amin Delparish, Matthieu Dorbec, John van der Schaaf, Timothy Noël","doi":"10.1021/acs.oprd.4c00458","DOIUrl":"https://doi.org/10.1021/acs.oprd.4c00458","url":null,"abstract":"Photochemical transformations have garnered renewed interest over the past decade for their ability to enable unique reactions under mild conditions. However, scaling up such processes, particularly in multiphase systems (e.g., gas–liquid), remains challenging. Previously, we demonstrated the potential of the photochemical rotor-stator spinning disc reactor (pRS-SDR) for scaling the photooxidation of α-terpinene to ascaridole, though the system was limited by the light source, resulting in suboptimal operation in a photon-limited regime. In this work, we unlock the full potential of the pRS-SDR by integrating a high-powered light source (up to 652 W optical output) specifically designed for the reactor. The results show that the high gas–liquid mass transfer rates achievable in the pRS-SDR allow for significant productivity improvements under high irradiance (16.3 kg day<sup>–1</sup> at 92% α-terpinene conversion and 2.52 W cm<sup>–2</sup> in a 27 mL irradiated volume), representing an order of magnitude increase compared to our previous study. However, the photooxidation of β-citronellol exhibited notable limitations, highlighting the importance of selecting appropriate model reactions when evaluating intensified photochemical reactors.","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"28 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142975666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Continuous Hydrogenation Reactor Based on a Powdered Catalyst Enmeshed in an Expanded Poly(tetrafluoroethylene) Matrix 基于扩展聚四氟乙烯基质的粉末催化剂连续加氢反应器
IF 3.4 3区 化学
Organic Process Research & Development Pub Date : 2025-01-14 DOI: 10.1021/acs.oprd.4c00303
Sean Breen, Purnima Barua, Yuan-Qing Fang, David D. Ford, Ali Hasan, Manish Joshi, Sara Mason, Kevin D. Nagy, Sifat bin Quadery, Grace Russell, Vladimiros Nikolakis, John D. Holcombe, Andrea Adamo, Lorenzo Milani
{"title":"A Continuous Hydrogenation Reactor Based on a Powdered Catalyst Enmeshed in an Expanded Poly(tetrafluoroethylene) Matrix","authors":"Sean Breen, Purnima Barua, Yuan-Qing Fang, David D. Ford, Ali Hasan, Manish Joshi, Sara Mason, Kevin D. Nagy, Sifat bin Quadery, Grace Russell, Vladimiros Nikolakis, John D. Holcombe, Andrea Adamo, Lorenzo Milani","doi":"10.1021/acs.oprd.4c00303","DOIUrl":"https://doi.org/10.1021/acs.oprd.4c00303","url":null,"abstract":"Fixed bed catalytic reactors are commonly used for hydrogenation in the commodity chemical industry, but adoption in the pharmaceutical industry has been limited by the lack of available catalyst pellets in sizes suitable both for process research and development at scales of 1–50 g substrate per experiment and also for to manufacturing at the metric ton scale. Herein, we describe an approach for continuous flow hydrogenation using catalytic cartridges of powdered catalysts (palladium on carbon in this example) enmeshed in an expanded poly(tetrafluoroethylene) (ePTFE) matrix. Using a modular design, the catalytic layers and supplemental components can be arranged to suit specific reaction conditions, desired results, and throughput. The reactor was demonstrated with three classes of hydrogenation reactions: nitro reduction, debenzylation, and alkene reduction. All substrates could achieve high or full conversion after optimization. The study also includes longevity experiments to understand the long-term reliability of the reactor as well as preliminary results for scaling up to a larger membrane size. The results make this technology promising for scale-up opportunities by using the same modular design.","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"5 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142975664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Achieving New Scales: The First Successful Pilot Plant Spherical Crystallization 实现新规模:第一个成功的球形结晶中试工厂
IF 3.4 3区 化学
Organic Process Research & Development Pub Date : 2025-01-13 DOI: 10.1021/acs.oprd.4c00350
Stephanie C. Kosnik, Zeno Leuter, Kevin Schwickert
{"title":"Achieving New Scales: The First Successful Pilot Plant Spherical Crystallization","authors":"Stephanie C. Kosnik, Zeno Leuter, Kevin Schwickert","doi":"10.1021/acs.oprd.4c00350","DOIUrl":"https://doi.org/10.1021/acs.oprd.4c00350","url":null,"abstract":"Spherical crystallization is a widely used technique for the preparation of spherically shaped agglomerates of crystalline material, which results in free-flowing powders with improved micromeritic properties. In this study, we applied this technique to the reactive crystallization of 3-iodo-7-methyl-1<i>H</i>-indazole, a critical early intermediate for one of our Active Pharmaceutical Ingredients at Boehringer Ingelheim. We utilized a traditional spherical agglomeration approach to identify a bridging liquid that could be easily implemented into the current crystallization process. Our experiments showed that the amount and rate of antisolvent addition were important for the crystallization; however, the stir rate and the amount of bridging liquid were the most critical factors. We successfully scaled up this process to a 300 L pilot plant reactor, keeping a constant power per unit mass during scale-up. The results showed that the spherical crystallizations for both 300 L batches were highly successful with almost identical particle sizes.","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"47 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142968524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting Shock Sensitivity from Differential Scanning Calorimetry Data and Molecular Structure: Beyond the Yoshida Correlation 从差示扫描量热数据和分子结构预测冲击敏感性:超越吉田相关性
IF 3.4 3区 化学
Organic Process Research & Development Pub Date : 2025-01-13 DOI: 10.1021/acs.oprd.4c00439
Eric L. Margelefsky, Benjamin C. Dobson, Tao Chen, Nelson Lee Afanador
{"title":"Predicting Shock Sensitivity from Differential Scanning Calorimetry Data and Molecular Structure: Beyond the Yoshida Correlation","authors":"Eric L. Margelefsky, Benjamin C. Dobson, Tao Chen, Nelson Lee Afanador","doi":"10.1021/acs.oprd.4c00439","DOIUrl":"https://doi.org/10.1021/acs.oprd.4c00439","url":null,"abstract":"The Yoshida correlation is widely used in the pharmaceutical and fine chemical industry to predict explosivity and shock sensitivity of chemical substances based on the initiation temperature and enthalpy of differential scanning calorimetry (DSC) exotherms. We investigate the origins and accuracy of this correlation (and commonly used modifications thereof) by applying it to a large data set of 383 compounds, which are relevant to the pharmaceutical industry, and demonstrate that the initiation temperature and enthalpy variables are not good predictors for shock sensitivity. By incorporating structural information (for the 292 compounds where it was available), we used machine learning to inform and guide a logistic regression technique to develop a shock sensitivity model which has a higher overall accuracy (63%) and a higher accuracy for shock-sensitive compounds (97%) compared to the original Yoshida correlation (52% overall accuracy, 82% accuracy for shock-sensitive compounds). This logistic regression model includes both the original Yoshida variables (DSC initiation temperature and enthalpy) and also incorporates the oxygen balance (OB<sub>100</sub>) and the number of energetic nitrogen groups in the molecule.","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"4 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142968525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuous Flow Telescopic Synthesis of 3-Methoxy Propiophenone by the Grignard Reaction 连续流动缩合Grignard反应合成3-甲氧基丙烯酮
IF 3.4 3区 化学
Organic Process Research & Development Pub Date : 2025-01-10 DOI: 10.1021/acs.oprd.4c00447
Pranali Wankhede, Amol A. Kulkarni
{"title":"Continuous Flow Telescopic Synthesis of 3-Methoxy Propiophenone by the Grignard Reaction","authors":"Pranali Wankhede, Amol A. Kulkarni","doi":"10.1021/acs.oprd.4c00447","DOIUrl":"https://doi.org/10.1021/acs.oprd.4c00447","url":null,"abstract":"The synthesis of 3-methoxypropiophenone <b>1</b>, a crucial intermediate in the production of the analgesic tapentadol hydrochloride, was investigated using a multistep continuous flow process. The approach is based on the Grignard reaction. A series of continuously stirred tank reactors (CSTRs) were employed: the first reactors facilitated the continuous generation of Grignard reagents <b>3</b>, which then reacted with propionitrile in the next CSTR to yield <b>1</b>. This was followed by quenching, neutralization, and phase separation, conducted under varying temperatures and residence times. When compared to a 50% yield from an optimized batch synthesis protocol, a continuous flow synthesis helped achieve an 84% yield of the desired product in a much shorter reaction time. A kinetic model was developed to predict the Grignard reagent formation and product yield, revealing that the mass transfer effect is insignificant at a higher stirring rate. The approach is highly scalable for the synthesis of pharmaceutical intermediates.","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"45 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142940603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Peptides Control Strategy: Perspective on Current Industry Practices 治疗性多肽控制策略:当前工业实践的观点
IF 3.4 3区 化学
Organic Process Research & Development Pub Date : 2025-01-09 DOI: 10.1021/acs.oprd.4c00386
Brian W. Pack, Jeremy Manheim, Osama Chahrour, Brandon Wood, Limin Zhang, Ulf Vogel, Gracie Sheng
{"title":"Therapeutic Peptides Control Strategy: Perspective on Current Industry Practices","authors":"Brian W. Pack, Jeremy Manheim, Osama Chahrour, Brandon Wood, Limin Zhang, Ulf Vogel, Gracie Sheng","doi":"10.1021/acs.oprd.4c00386","DOIUrl":"https://doi.org/10.1021/acs.oprd.4c00386","url":null,"abstract":"There is currently a lack of harmonization from health agencies on the control strategies that should be implemented for the manufacture of synthetic peptide active pharmaceutical ingredients throughout clinical development and commercialization. In this Perspective, we use the term “peptide” to refer to an α-amino acid polymer with a specific defined sequence without regard to the total number of amino acids that it contains. In the U.S., the FDA currently defines “proteins” that are subject to biological product licensure as follows: “A protein is any alpha amino acid polymer with a specific, defined sequence that is greater than 40 amino acids in size. When two or more amino acid chains in an amino acid polymer are associated with each other in a manner that occurs in nature, the size of the amino acid polymer for purposes of this paragraph (h)(6) will be based on the total number of amino acids in those chains, and will not be limited to the number of amino acids in a contiguous sequence” [21 CFR 600.3(h)(6)]. In contrast, other regulatory authorities apply requirements based on the method of manufacture, resulting in regulatory risks of disparate requirements depending on the jurisdiction. To provide visibility into current industry practices on the control strategies applied to synthetic peptides, a benchmark survey of member companies of the IQ Consortium was conducted. This work provides a comprehensive analysis of the survey results. The compiled responses from 10 companies reveal that while most follow similar control strategies for identification, purity, and assay testing, none of the survey questions received a unanimous response. Interestingly, the number and type of analytical techniques utilized for each test differed when comparing the phase of development, the number of amino acids in the peptide, and whether it was for the drug substance or drug product. Additionally, the limits set for impurity reporting, identification, and qualification thresholds throughout development varied widely. The knowledge acquired from the survey in combination with previously published literature and individual company experiences enables the IQ Consortium to put forth appropriate recommendations to achieve harmonization of control strategies for synthetic peptides with regard to assay, identity, impurity reporting and identification thresholds, bioassay, and comparability assessments.","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"14 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142940605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coupled-Batch Preferential Crystallization of Imeglimin Propionate on a 200 g Scale 200 g丙酸依米明的间歇优先结晶
IF 3.4 3区 化学
Organic Process Research & Development Pub Date : 2025-01-08 DOI: 10.1021/acs.oprd.4c00291
Leela Christian-Tabak, Koji Machida, Hideo Kawachi, Hiroaki Tanaka, Kazuki Hashimoto
{"title":"Coupled-Batch Preferential Crystallization of Imeglimin Propionate on a 200 g Scale","authors":"Leela Christian-Tabak, Koji Machida, Hideo Kawachi, Hiroaki Tanaka, Kazuki Hashimoto","doi":"10.1021/acs.oprd.4c00291","DOIUrl":"https://doi.org/10.1021/acs.oprd.4c00291","url":null,"abstract":"The application of coupled-batch preferential crystallization (CB-PC) for the propionate salt of the active pharmaceutical ingredient imeglimin is demonstrated herein. Process conditions were chosen based on metastable zone width measurements, and an apparatus with 500 mL-sized crystallization vessels was constructed. A series of CB-PC experiments on an increasing scale were run, and observations on scaling up were made throughout, including the effect of the seeding method, productivity over time, and physical limits of the apparatus. The series culminated in two successive runs each on a 200 g scale, in which the mother liquor from the first run was recycled to the second.","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"7 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142935909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scalable Flow Electrosynthesis of Iminophosphoranes 可扩展流动电合成亚磷酸烷
IF 3.4 3区 化学
Organic Process Research & Development Pub Date : 2025-01-07 DOI: 10.1021/acs.oprd.4c00372
Dan Lehnherr, Longrui Chen, François Lévesque, Christopher Nietupski, Mark Weisel, Velabo Mdluli, Keith Mattern, Brittany M. Armstrong, Tao Chen, Ryan D. Cohen
{"title":"Scalable Flow Electrosynthesis of Iminophosphoranes","authors":"Dan Lehnherr, Longrui Chen, François Lévesque, Christopher Nietupski, Mark Weisel, Velabo Mdluli, Keith Mattern, Brittany M. Armstrong, Tao Chen, Ryan D. Cohen","doi":"10.1021/acs.oprd.4c00372","DOIUrl":"https://doi.org/10.1021/acs.oprd.4c00372","url":null,"abstract":"A scalable electrochemical process to synthesize iminophosphorane ligands is reported. The application of these iminophosphoranes was recently reported in Ni-catalyzed cross-electrophile and C–N cross-couplings. The use of parallel plate flow electrochemical reactors enables the synthesis of these iminophosphorane ligands on a multigram scale, with selected examples reported on up to 0.6 kg scale. Direct crystallization from the end of reaction mixture for selected ligands provides facile isolation processes. This article also details improvements in our electrochemical capabilities across scales, including addressing material compatibility issues, increasing accessible range of flow rates, and integration of process analytical technology tools.","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"2 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142935911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterization of Amorphous Ibrutinib Thermal Stability 非晶伊鲁替尼热稳定性表征
IF 3.4 3区 化学
Organic Process Research & Development Pub Date : 2025-01-07 DOI: 10.1021/acs.oprd.4c00299
Dan Trunov, Jan Ižovský, Josef Beranek, Ondřej Dammer, Miroslav Šoóš
{"title":"Characterization of Amorphous Ibrutinib Thermal Stability","authors":"Dan Trunov, Jan Ižovský, Josef Beranek, Ondřej Dammer, Miroslav Šoóš","doi":"10.1021/acs.oprd.4c00299","DOIUrl":"https://doi.org/10.1021/acs.oprd.4c00299","url":null,"abstract":"The choice of method for drug amorphization depends on various factors, including the physicochemical properties of the active pharmaceutical ingredients, the desired formulation, and scalability requirements. It is often important to consider a combination of methods or the use of excipients to further enhance the stability and performance of the amorphous drug. This study presents a comparison of techniques including melt quench, hot melt extrusion, solvent evaporation, ball milling, and lyophilization used for the preparation of amorphous ibrutinib. The amorphous material was thoroughly investigated using numerous techniques to examine changes in the physicochemical properties, stability, and degradation pathways of the drug product. During the examination, the temperature was discovered to be a key parameter for controlling the solubility and permeability of ibrutinib, which is influenced by the presence of the degradation product. We found that this degradation product could potentially polymerize and increase the molecular weight. The quantity, polymerization rate, and structure of the impurity can be regulated by the temperature variation during the amorphization processes. Additionally, the molecular weight of the degradation product was determined using Zimm plot analysis, which appeared for the first time in the literature for molecules of this category.","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"98 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142935910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信